Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, today announced the launch of its ground-breaking service offering, OrganoidXploreTM.